HNCA Board Member, Dr. Ezra Cohen was the Chair and Featured Presenter for Symposium Held on February 14th

HNCA, in collaboration with PeerView, hosted an educational symposium on February 14th — Solving the MultiModal Puzzle of Head and Neck Cancer in the Immunotherapy Era — which was held in Scottsdale, Arizona.

HNCA Board Member Dr. Ezra Cohen was the symposium chair and featured presenter; he was joined by Barbara Burtness, M.D., Yale University School of Medicine and Andrew Sharabi, M.D., Ph.D., University of California, San Diego.

One of the symposium highlight’s was a video presentation of James Lyons, a retired Bridgeport, Connecticut police officer who recently underwent successful treatment with immunotherapy for tongue cancer.

This event was PeerView’s latest CME/CE/CPE-accredited live/on-demand satellite symposium covering the continuing march of immune therapy in head and neck cancer.

View an Uncut Video of the Symposium



As a decade-long survivor of stage IV tongue cancer and Founder of WesternOhio Oral, Head and Neck Cancer Support, Hank refers to head and neck cancer as an “orphan” cancer: “Very little is known about head and neck cancer, and comparatively, it receives less attention than other cancers. HNCA is working to change this.Hank Deneski
Survivor of Stage IV tongue cancer and Founder of WesternOhio Oral, Head and Neck Cancer Support

Thank You to Our Corporate and Community Partners